| Literature DB >> 34273940 |
Mahboubeh Parsaeian1, Mahdi Mahdavi2,3, Mojdeh Saadati4, Parinaz Mehdipour5, Ali Sheidaei6, Shahab Khatibzadeh7, Farshad Farzadfar5,8, Saeid Shahraz9.
Abstract
BACKGROUND: Sampling a small number of participants from an entire country is not straightforward. In this case, researchers reluctantly sample from a single setting or few settings, which limits the generalizability of findings. Therefore, there is a need to design efficient sampling method for small sample size surveys that can produce generalizable results at the country level.Entities:
Keywords: Iran quality of Care in Medicine Program (IQCAMP); Model-based clustering; Sampling efficiency; Small sample size; Survey sampling method; Validity
Mesh:
Year: 2021 PMID: 34273940 PMCID: PMC8285867 DOI: 10.1186/s12889-021-11441-0
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Main steps of the study methods; clustering, validity assessment, and extracting features of clusters
Note: An expert panel checked the face validity of all steps
Definition of health demands, health services structures and health outcomes indicators included in the clustering methods
| Factor | Variable name | Variable definition | Geographical unit | Data Source | Year |
|---|---|---|---|---|---|
| Demand/Disease patterns | Inpatient | Annual average number of inpatient | District | Utilization | 2014 |
| Outpatients | Annual average number of outpatient | District | Utilization | 2014 | |
| Hospitalization rate | Hospitalization rate per 1000 population | Province | Hospital Data | 2011 | |
| Patient exchange rate | Ratio of sending referrals to receiving referrals (Patient exchange rate) | Province | Hospital Data | 2011 | |
| SBP | Mean SBP among hypertensive patients | District | STEPs | 2016 | |
| Glucose | Mean of glucose among patients with DM | District | STEPs | 2016 | |
| Cholesterol | Mean cholesterol among patients with hyperlipidemia | District | STEPs | 2016 | |
| Structure | Basic insurance coverage | Basic insurance coverage (% of the population with basic insurance) | District | Utilization | 2014 |
| Complementary insurance coverage | Complementary insurance coverage (% of the population with complementary insurance) | District | Utilization | 2014 | |
| Bed density | Number of beds per 1000 population | Province | Hospital Data | 2011 | |
| Physician density | Number of physicians per 1000 population | Province | Hospital Data | 2011 | |
| Outcome | Probability of dying from IHD | Probability of dying from IHD* among adults (age ≥ 30) | Province | DRS | 2015 |
| Probability of dying from Stroke | Probability of dying from Stroke among adults (age ≥ 30) | Province | DRS | 2015 | |
| Probability of dying from COPD | Probability of dying from COPD* among adults (age ≥ 30) | Province | DRS | 2015 | |
| Probability of dying from Diabetes | Probability of dying from Diabetes mellitus among adults (age ≥ 30) | Province | DRS | 2015 | |
| Probability of dying from CKD | Probability of dying from CKD* among adults (age ≥ 30) | Province | DRS | 2015 | |
| Neonatal mortality rate | Neonatal mortality per 1000 live births | Province | DRS | 2015 | |
| Adverse effect mortality | Mortality rate due to the adverse effect of medical treatment | Province | DRS | 2015 | |
| All-cause mortality ratio | Expected mortality rate to observed mortality rate | Province | DRS | 2015 | |
| Mortality rate in hospital | Mortality rate among 1000 hospitalized patients | Province | Hospital Data | 2011 |
SBP Systolic Blood Pressure, DM Diabetes Mellitus, IHD Ischemic Heart Disease, COPD Chronic Obstructive Pulmonary Disease, CKD Chronic Kidney Disease
District is defined as a geographical region with administrative boundaries and an independent network of healthcare provisioning. Province comprises a set of districts and has few managerial authorities in planning and organization of health services. Provincial level is the first level of country subdivisions. Input data consist of data from 31 provinces and 413 districts of Iran
Utilization study measures the use of inpatient and outpatient health services by individuals using a representative sample of population
STEPs is a national survey based on the WHO stepwise approach to study non-communicable disease risk factors
DRS abbreviates Death Registration System
Hospital Data is a research project that studies 0.5% of all inpatient cases in hospitals owned by Ministry of Health and Medical Education in 2011 in Iran
The adverse effect of medical treatment refers to unintended consequences of any types of medical interventions including prevention, diagnosis, treatment, and rehabilitation
Fig. 2Proposed number of clusters by NbClust package
Comparison of internal and stability validity by clustering methods
| Validity Indexes | MCM-8 | HCM-2 | HCM-8 |
|---|---|---|---|
| Internal Validity Indexes | |||
| Within-clusters Sum of Squaresa | 384.55 | 292.65 | |
| Average silhouette widthb | 0.14 | 0.09 | |
| Dunn indexb | 0.20 | 0.19 | |
| Stability Validity Indexes | |||
| Average Proportion of Non-overlap (APN)c | 0.13 | 0.19 | |
| Average Distance ADc | 1.37 | 1.24 | |
| Average distance between means (ADM)c | 0.19 | 0.28 | |
| Figure of Merit (FOM)c | 0.24 | 0.22 | |
a The lower the value of the within-cluster sum of square, the higher the extent of compactness
b The higher the value of Dunn index and average silhouette width, the higher the extent of compactness and separation
c For all stability indices, smaller values indicate better stability validity
Fig. 3Geographic distribution of 8 clusters identified by the Model-based Clustering Method
Fig. 4Using decision tree learning to describe distinctive features of 8 clusters identified by the Model-based Clustering Method
Comparison of efficiency of clustering-based sampling to SRS based on distinct cluster features
| Variables | Sampling efficiency |
|---|---|
| The ratio of sending referrals to receiving referrals (Patient exchange rate) | 1.5 |
| The probability of dying from Stroke (age ≥ 30) | 1.7 |
| The probability of dying from COPDa (age ≥ 30) | 1.5 |
| The probability of dying from CKDb (age ≥ 30) | 1.4 |
| The mortality rate attributed to the adverse effect of medical treatment | 1.2 |
| Expected mortality rate to observed mortality rate | 1.3 |
| The mortality rate among 1000 hospitalized patients | 1.4 |
a COPD: Chronic Obstructive Pulmonary Disease
b CKD: Chronic Kidney Disease